Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by freedom2020on Dec 13, 2015 4:21pm
455 Views
Post# 24381247

Cystic Fibrosis is my guess

Cystic Fibrosis is my guess
Like some other posters here I suspect the next orphan indication for PBI-4050
will be Cystic Fibrosis.
 
On Monday my guess (opinion) news will come out that we will be receiving money 
awards from a "Cystic Fibrosis Foundation?" for a phase II trial.
 
my reasons:
A company called Corbus Pharmaceuticals recently received a 5.0 million "CFF award" for
there CF Drug "Resunab" currently in phase II trials, why not us as well???...right
 
PBI-4050 already in the middle of Phase II open label in canada for IPF
PBI-4050 receives pivotal trial in the USA for IPF
PBI-4050 granted orphan indication in Europe for IPF
 
The above screams the Canadian PBI-4050 IPF trials are proceeding very well,
we already know the next PBI-4050 orphan will jump right into Phase II.
 
I know it's a long shot but this makes the most sense to me after
interpeting the latest and pending news coming Monday.
 
La belle Celine de la province de Quebec soutient les fondations de la fibrose kystique :-)
fetes vos recherches mes amis what else could it be...
 
All this above is just my opinion from internet research.
Freedom2020
Bullboard Posts